Prevalence and Treatment Adequacy of Migraine Among Semi Urban Population in Chennai

  • Balaji Arumugam Assoicate Professor, Department of Community Medicine
  • B Kailaash Final Year MBBS Part I Students
  • R Vijay Thiraviyam Final Year MBBS Part I Students
  • S Ganesh Kumar Final Year MBBS Part I Students
  • C Thirugnanasambandhan Final Year MBBS Part I Students
Keywords: Headache disorders, Migraine headache, Status migrainosus


Introduction: Migraine is a common disorder having a signifi cant impact on the quality of daily life. Despite the fact, migraine
largely remains an under diagnosed and an undertreated condition. The study aims to assess the prevalence, distribution,
treatment patterns and success among migraineurs.
Material and Methods: The study was conducted as a community based study using Kiel headache questionnaire developed
based on the International Headache Society criteria for migraine. A visual acuity score chart was be used to establish treatment
success. Study population and area: This study was done among adults 18 years and above with history of headaches for more
than a year in the fi eld practice area of the Community Medicine Department of TMCH during May to June 2014. Sample size:
The sample size calculated was 340 (with the existing prevalence of 22.7% and 20% allowable error). Statistical technique:
Data were entered in Excel sheet and analysis were be done using SPSS software.
Results: The prevalence of migraine among the 499 people who were sampled was 32%, while that of classical migraine was
11.2%. There was a female preponderance in the prevalence of migraine. Females accounted for 59.6% of the migraineurs
and it was highly prevalent in adults among 31-45 years, who constituted 38% of the migraineurs. Prevalence of migraine was
comparatively higher in people of socio-economic class 1 with 39.6% having migraine. Despite the frequency and severity of
headaches only 32% of the migraineurs had sought physician consult, 39.6% claimed not taking any medicines and the rest
were on self-medication. The treatment success rate was 38.3% and 1% of the study population had migraine prophylactic drugs.
Conclusion: Despite the higher prevalence of migraine in this population than the global prevalence, majority of them do not
seek proper medical treatment.

Author Biographies

Balaji Arumugam, Assoicate Professor, Department of Community Medicine

Tagore Medical College and Hospital, Chennai, Tamil Nadu, India

B Kailaash, Final Year MBBS Part I Students

Tagore Medical College and Hospital, Chennai, Tamil Nadu, India

R Vijay Thiraviyam, Final Year MBBS Part I Students

Tagore Medical College and Hospital, Chennai, Tamil Nadu, India

S Ganesh Kumar, Final Year MBBS Part I Students

Tagore Medical College and Hospital, Chennai, Tamil Nadu, India

C Thirugnanasambandhan, Final Year MBBS Part I Students

Tagore Medical College and Hospital, Chennai, Tamil Nadu, India


1. Lipton RB, Bigal ME, Scher AI, Stewart WE. The global burden of
migraine. J Headache Pain 2003;4:S3-11.
2. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine
headache in the United States. Relation to age, income, race, and other
sociodemographic factors. JAMA 1992;267:64-9.
3. Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of
migraine: Measuring disability in headache disorders with WHO’s
Classifi cation of Functioning, Disability and Health (ICF). J Headache Pain
4. Kalaydjian A, Merikangas K. Physical and mental comorbidity of headache
in a nationally representative sample of US adults. Psychosom Med
5. Göbel H. Classifi cation of headache: Criteria and practical implementation.
Z Arztl Fortbild (Jena) 1993;87:451-8.
6. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The
global burden of headache: A documentation of headache prevalence and
disability worldwide. Cephalalgia 2007;27:193-210.
7. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by
race. Neurology 1996;47:52-9.
8. Lipton RB, Bigal ME. The classifi cation of migraine. In: Olesen J, editor.
Classifi cation and Diagnosis of Headache Disorders. New Delhi: Oxford
University Press; 2006. p. 53-61.
9. Ojini FI, Okubadejo NU, Danesi MA. Prevalence and clinical characteristics
of headache in medical students of the University of Lagos, Nigeria.
Cephalalgia 2009;29:472-7.
10. Tepper SJ. A pivotal moment in 50 years of headache history: The fi rst
American Migraine Study. Headache 2008;48:730-1.
11. Kelman L. Pain characteristics of the acute migraine attack. Headache
12. Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers
in a clinic-based population. Headache 2010;50:1366-70.
13. Sanvito WL, Monzillo PH, Peres MF, Martinelli MO, Fera MP,
Gouveia DA, et al. The epidemiology of migraine in medical students.
Headache 1996;36:316-9.
14. Available from:
fact-sheet.html. [Last accessed on 2014 Oct 29].
15. Finocchi C, Sivori G. Food as trigger and aggravating factor of migraine.
Neurol Sci 2012;33 Suppl 1:S77-80.
16. Manack AN, Buse DC, Lipton RB. Chronic migraine: Epidemiology and
disease burden. Curr Pain Headache Rep 2011;15:70-8.
17. Sedighi B, Ghaderi-Sohi S, Emami S. Evaluation of self-medication
prevalence, diagnosis and prescription in migraine in Kerman, Iran. Saudi
Med J 2006;27:377-80.
18. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine:
Results from the American Migraine Study. Headache 1998;38:87-96.
19. Guitera V, Muñoz P, Castillo J, Pascual J. Quality of life in chronic daily
headache: a study in a general population. Neurology 2002;58:1062-5.
20. McCrory DC, Gray RN. Withdrawn: Oral sumatriptan for acute migraine.
Cochrane Database Syst Rev 2012;2:CD002915.